License and supply agreement with Genuine Health
RNS & Investor News
Further re Open Offer
03 February 2014
Further to the announcement made on 30 January 2014 the Company wishes to clarify the timetable and principal events in relation to the Open Offer.
The timetable published in the Open Offer document posted to shareholders on 30 January 2014 contained the expected timetable and principal events as set out in the table below.
The timetable did not state an ex-entitlement date, which was advised as being 30 January 2014 in the accompanying application form posted to shareholders.
The Company has now agreed to set the ex-entitlement date as 4 February 2014, therefore it has requested the London Stock Exchange to add an "ex-marker" to the Company's shares from the commencement of trading on 4 February 2014.
For the avoidance of doubt the record date for entitlement under the Open Offer remains 5pm on 18 November 2013.
Expected Timetable and Principal Events (revised)
|Record Date for entitlement under the Open Offer||5 p.m. on 18 November 2013|
|Announcement and Circular published||30 January 2014|
|Ex-entitlement date||4 February 2014|
|Last time and date for splitting of Application Forms (to satisfy bona fide market claims only)||3 p.m. on 10 February 2014|
|Latest time and date for receipt of completed Application Forms and payment in full under the Open Offer||11 a.m. on 14 February 2014|
|Admission and commencement of dealings in New Ordinary Shares||8 a.m. on 20 February 2014|
|CREST members' accounts credited in respect of Offer Shares in uncertificated form||20 February 2014|
|Despatch of definitive share certificates for Offer Shares in certificated form by not later than||27 February 2014|
For further information, please contact:
|Ducat Ventures plc||Nicholas Nelson||+44 (0)79 2152 2920|
|Cairn Financial Advisers LLP||Liam Murray / Jo Turner||+44 (0)20 7148 7900|
|Peterhouse Corporate Finance Ltd||Lucy Williams/ Fungai Ndoro||+44 (0)20 7469 0936|
OptiBiotix Health secures significant exclusive licence agreement for OptiBiome
Stephen O'Hara | 01 Apr 2020